Multiple venous variations at the abdominopelvic region: a case report.

Anat Cell Biol

Department of Mathematics, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Published: September 2022

Knowledge of vascular variations of the abdominopelvic junction is of importance to surgeons, radiologists, orthopaedic surgeons and other medical disciplines. We report a rare combination of venous variations observed at the abdominopelvic junction of an adult male cadaver. The right common iliac vein was absent. The inferior vena cava was formed by the union of the right external iliac vein and the left common iliac vein. The right internal iliac vein was a tributary of the left common iliac vein. The left common iliac vein was larger than usual in size and its wall was adhered to the right common iliac artery. We discuss the functional, developmental and clinical issues related to the case.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519772PMC
http://dx.doi.org/10.5115/acb.22.066DOI Listing

Publication Analysis

Top Keywords

iliac vein
24
common iliac
20
left common
12
venous variations
8
variations abdominopelvic
8
abdominopelvic junction
8
vein left
8
iliac
7
vein
6
common
5

Similar Publications

Objective: The objective of this study is to assess the feasibility of endovascular coiling combined with tissue glue embolism for the treatment of iliac arteriovenous fistula (AVF) secondary to deep vein thrombosis (DVT) of the lower extremities. In addition, we aim to summarize the treatment methods and enhance understanding of the disease.

Methods: This research analyzes the clinical data and medical imaging materials of 20 cases with iliac AVF secondary to lower extremity DVT, ranging from December 2014 to December 2020, at our hospital.

View Article and Find Full Text PDF

Background: In patients with post-thrombotic syndrome (PTS), stent recanalization of iliofemoral veins or the inferior vena cava can restore venous patency and improve functional outcomes. The risk of stent thrombosis is particularly increased during the first 6 months after intervention. The ARIVA trial tested whether daily aspirin 100 mg plus rivaroxaban 20 mg is superior to rivaroxaban 20 mg alone to prevent stent thrombosis within 6 months after stent placement for PTS.

View Article and Find Full Text PDF

Pelvic Venous Disorder (PEVD) and May-Thurner syndrome (MTS) represent relatively understudied vascular issues that can significantly impact patients' quality of life. This study aims to evaluate the efficacy of surgical treatment for PEVD and MTS, conduct a comparative analysis of outcomes, and determine the practical significance of different therapeutic approaches. The study was conducted from 2019 to 2022 in Moscow, Russia, encompassing two outpatient clinics.

View Article and Find Full Text PDF

Purpose: To explore the anatomical features of left iliac vein (LIV) in non-thrombotic venous leg ulcers (VLUs) and to identify the impact of these anatomical features on VLUs based on computed tomography venography (CTV).

Methods: This is a retrospective, single-center study of a database (2021-2023) of 431 patients with non-thrombotic chronic venous insufficiency. According to CEAP clinical (C) classifications, cases of C6 and C2 were included for analysis as case and control groups.

View Article and Find Full Text PDF

Purpose: To evaluate longer term outcomes of the Zilver Vena Venous Stent in patients undergoing venous stenting.

Materials And Methods: Patients with iliofemoral obstructive venous disease and treated with venous stents were retrospectively enrolled in a physician-led real-world data collection effort. Results were analyzed by etiologies: post-thrombotic syndrome (PTS), non-thrombotic iliac vein lesion (NIVL), and iliocaval acute deep vein thrombosis (aDVT).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!